Jinling Pharmaceutical Co Ltd (000919) — Financial Flexibility Index
Jinling Pharmaceutical Co Ltd (000919) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of CN¥86.57 Million (operating CF CN¥74.01 Million minus capex CN¥12.56 Million) represents 0% of total liabilities (CN¥1.18 Billion). Also explore Jinling Pharmaceutical Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jinling Pharmaceutical Co Ltd Financial Flexibility Index (1999–2024)
Historical Financial Flexibility Index trend for Jinling Pharmaceutical Co Ltd across 26 annual periods. Check how strategically is Jinling Pharmaceutical Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Jinling Pharmaceutical Co Ltd (1999–2024)
Year-by-year free cash flow to debt coverage for Jinling Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 000919 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.29x | CN¥355.82 Million | CN¥154.19 Million | CN¥1.24 Billion | ▼ -28.1% |
| 2023 | 0.40x | CN¥345.18 Million | CN¥158.92 Million | CN¥865.58 Million | ▼ -35.9% |
| 2022 | 0.62x | CN¥570.23 Million | CN¥260.59 Million | CN¥916.30 Million | ▲ +24.9% |
| 2021 | 0.50x | CN¥454.79 Million | CN¥292.03 Million | CN¥913.10 Million | ▼ -29.7% |
| 2020 | 0.71x | CN¥602.87 Million | CN¥311.46 Million | CN¥850.43 Million | ▼ -12.1% |
| 2019 | 0.81x | CN¥591.56 Million | CN¥465.85 Million | CN¥733.62 Million | ▼ -9.7% |
| 2018 | 0.89x | CN¥570.25 Million | CN¥433.83 Million | CN¥638.90 Million | ▲ +40.6% |
| 2017 | 0.63x | CN¥509.90 Million | CN¥443.11 Million | CN¥803.11 Million | ▲ +151.0% |
| 2016 | 0.25x | CN¥203.60 Million | CN¥96.15 Million | CN¥804.90 Million | ▼ -26.1% |
| 2015 | 0.34x | CN¥316.76 Million | CN¥212.45 Million | CN¥925.73 Million | ▼ -23.8% |
| 2014 | 0.45x | CN¥391.03 Million | CN¥299.89 Million | CN¥871.24 Million | ▼ -21.1% |
| 2013 | 0.57x | CN¥415.26 Million | CN¥271.21 Million | CN¥729.94 Million | ▼ -0.9% |
| 2012 | 0.57x | CN¥420.88 Million | CN¥232.12 Million | CN¥733.12 Million | ▲ +42.5% |
| 2011 | 0.40x | CN¥255.03 Million | CN¥172.82 Million | CN¥633.01 Million | ▼ -19.7% |
| 2010 | 0.50x | CN¥273.29 Million | CN¥177.81 Million | CN¥544.47 Million | ▼ -29.5% |
| 2009 | 0.71x | CN¥285.01 Million | CN¥188.41 Million | CN¥400.59 Million | ▼ -29.5% |
| 2008 | 1.01x | CN¥327.38 Million | CN¥305.26 Million | CN¥324.25 Million | ▲ +202.7% |
| 2007 | 0.33x | CN¥139.03 Million | CN¥118.06 Million | CN¥416.86 Million | ▼ -31.8% |
| 2006 | 0.49x | CN¥161.59 Million | CN¥138.50 Million | CN¥330.39 Million | ▼ -6.0% |
| 2005 | 0.52x | CN¥145.90 Million | CN¥109.29 Million | CN¥280.42 Million | ▼ -27.7% |
| 2004 | 0.72x | CN¥232.28 Million | CN¥159.81 Million | CN¥322.83 Million | ▼ -15.7% |
| 2003 | 0.85x | CN¥218.59 Million | CN¥161.86 Million | CN¥256.06 Million | ▲ +8.7% |
| 2002 | 0.79x | CN¥232.99 Million | CN¥130.36 Million | CN¥296.79 Million | ▼ -4.8% |
| 2001 | 0.82x | CN¥252.77 Million | CN¥92.49 Million | CN¥306.54 Million | ▼ -63.6% |
| 2000 | 2.27x | CN¥365.80 Million | CN¥231.31 Million | CN¥161.37 Million | ▲ +212.0% |
| 1999 | 0.73x | CN¥111.34 Million | CN¥39.77 Million | CN¥153.24 Million | — |